Abstract
Ophthalmic drug delivery remains a significant challenge to the clinicians. A number of anatomic and physiological barriers restrict the entry of drug inside the ocular tissues, especially in the posterior segment of eye. The present review discusses various ocular barriers and drug factors which influence the ophthalmic drug delivery. Furthermore, recent advances in ophthalmic drug formulations attempted to overcome these barriers have been explored.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference78 articles.
1. Tripathi KD. Essentials of Medical Pharmacology. 7th ed. New Delhi: Jaypee Brother Medical Publishers; 2014. p. 16.
2. Satoskar RS, Rege NN, Bhandarkar SD. Pharmacology and Pharmacotherapeutics. 24th ed. Haryana: Elsevier; 2015. p. 12.
3. Kompella UB, Kadam RS, Lee VH. Recent advances in ophthalmic drug delivery. Ther Deliv 2010;1:435-56. doi: 10.4155/TDE.10.40, PMID 21399724.
4. Chan J, El Maghraby GM, Craig JP, Alany RG. Phase transition water-in-oil microemulsions as ocular drug delivery systems: In vitro and in vivo evaluation. Int J Pharm 2007;328:65-71. doi: 10.1016/j. ijpharm.2006.10.004, PMID 17092668.
5. Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J 2010;12:348-60. doi: 10.1208/s12248-010-9183-3, PMID 20437123.